novartis hits acquisition trail
swiss drugmaker novartis euros purchases sandoz unit generic drug producer
novartis forecast sales bought hexal acquired hexal affiliate eon labs remaining shares novartis acquisitions novartis shares swiss francs trading
novartis sandoz overtake israel teva pharmaceuticals maker generics newly merged producer sales estimated novartis merge departments adding
outlook sandoz partially compensate reductions generic drugs chemically identical expensive branded rivals producers sandoz copy branded products patent expires sell cheaply
generic drugmakers worldwide analysts consolidation fragmented analysts initially convinced expensive acquisition birgit kuhlhoff sal oppenheim investment bank reuters strange acquisitions markets suffered price
